228 results on '"Hanania, Taleen"'
Search Results
2. Computational Analysis of Multidimensional Behavioral Alterations After Chronic Social Defeat Stress
3. ANAVEX®2-73 (blarcamesine), a Sigma-1 receptor agonist, ameliorates neurologic impairments in a mouse model of Rett syndrome
4. Myelinated axons fail to develop properly in a genetically authentic mouse model of Charcot-Marie-Tooth disease type 2E
5. Reprint of: Highthroughtput analysis of behavior for drug discovery
6. High-throughput analysis of behavior for drug discovery
7. Discriminative stimulus properties of GABAA receptor positive allosteric modulators TPA023, ocinaplon and NG2-73 in rats trained to discriminate chlordiazepoxide or zolpidem
8. Sub-optimal performance in the 5-choice serial reaction time task in rats was sensitive to methylphenidate, atomoxetine and d-amphetamine, but unaffected by the COMT inhibitor tolcapone
9. Comparison of the predictive validity of the mirror chamber and elevated plus maze tests in mice
10. The modified Geller–Seifter test in rats was insensitive to GABAB receptor positive modulation or blockade, or 5-HT1A receptor activation
11. The high-affinity nAChR partial agonists varenicline and sazetidine-A exhibit reinforcing properties in rats
12. Psychostimulant-like discriminative stimulus and locomotor sensitization properties of the wake-promoting agent modafinil in rodents
13. Elevation of brain magnesium with Swiss chard and buckwheat extracts in an animal model of reduced magnesium dietary intake
14. Pharmacological characterization of harmaline-induced tremor activity in mice
15. Anxiolytic effects of lamotrigine and JZP-4 in the elevated plus maze and in the four plate conflict test
16. Elevation of brain magnesium with Swiss chard and buckwheat extracts in an animal model of reduced magnesium dietary intake.
17. Dissociation between duration of action in the forced swim test in mice and nicotinic acetylcholine receptor occupancy with sazetidine, varenicline, and 5-I-A85380
18. Translational aspects of pharmacological research into anxiety disorders: The stress-induced hyperthermia (SIH) paradigm
19. In vivo pharmacological effects of JZP-4, a novel anticonvulsant, in models for anticonvulsant, antimania and antidepressant activity
20. Behavior-Based Screening as an Approach to Polypharmacological Ligands
21. Aβ-accelerated neurodegeneration caused by Alzheimer’s-associated ACE variant R1279Q is rescued by angiotensin system inhibition in mice
22. Mouse model systems of autism spectrum disorder: Replicability and informatics signature
23. The N-methyl-D-aspartate receptor antagonist d-methadone acutely improves depressive-like behavior in the forced swim test performance of rats.
24. The nAChR agonist AMOP-H-OH (‘sazetidine-Aʼ) exhibits reinforcing, but not withdrawal-alleviating, properties in rats: 3.12
25. ANATOMY AND PHYSIOLOGY OF THE CENTRAL NERVOUS SYSTEM
26. Differential regulation of cocaine-induced locomotor activity in inbred long-sleep and short-sleep mice by dopamine and serotonin systems
27. Myelinated axons fail to develop properly in a genetically authentic mouse model of Charcot-Marie-Tooth disease type 2E
28. SEP-363856, a Novel Psychotropic Agent with a Unique, Non-D2 Receptor Mechanism of Action
29. Mouse Model Systems of Autism Spectrum Disorder: Replicability and Informatics Signature
30. Biomarker Analysis of Orally Dosed, Dual Active, Matrix Metalloproteinase (MMP)-2 and MMP-9 Inhibitor, AQU-118, in the Spinal Nerve Ligation (SNL) Rat Model of Neuropathic Pain
31. MK-801- and ethanol-induced activity in inbred long-sleep and short-sleep mice: dopamine and serotonin systems
32. P1‐488: BEHAVIORAL MANIFESTATIONS, AGRESSION AND PLAQUE DISTRIBUTION IN TRANSGENIC MOUSE MODELS OF ALZHEIMER'S DISEASE
33. Regulation of NMDA-stimulated [ [formula omitted]]GABA and [ [formula omitted]]acetylcholine release by striatal glutamate and dopamine receptors
34. Effect of a novel, orally active matrix metalloproteinease-2 and-9 inhibitor in spinal and trigeminal rat models of neuropathic pain
35. Early life diet containing prebiotics and bioactive whey protein fractions increased dendritic spine density of rat hippocampal neurons
36. Comprehensive Analysis of Two Shank3 and the Cacna1c Mouse Models of Autism Spectrum Disorder
37. P4‐039: Differences between TG2576‐ and APP/PS1 Mice in High‐Throughput Behavioral Screening Correlates with Differences in Brain Pathology
38. P3-068: Effects of Treatment With Doxycycline on Behavior, Neuroinflammation and Brain Pathology in the RTG-4510 Mouse Model
39. SEP-363856, a Novel Psychotropic Agent with a Unique, Non-D2Receptor Mechanism of Action▪
40. In vivo phenotypic drug discovery: applying a behavioral assay to the discovery and optimization of novel antipsychotic agents
41. Comprehensive Analysis of the 16p11.2 Deletion and Null Cntnap2 Mouse Models of Autism Spectrum Disorder
42. Noribogaine reduces nicotine self-administration in rats
43. Dendritic Spine Density of Rat Hippocampal Neurons is Increased Following Consumption of Diet Containing a Prebiotic Blend and Bioactive Whey Protein Fractions
44. Characterization of Noribogaine at nAChRs and Effect on Nicotine Self‐Administration in Rats
45. Dietary prebiotics improve memory and social interactions while reducing anxiety when provided early in life to normally developing rodents (637.5)
46. The potent and selective α 4 β 2*/ α 6*‐nicotinic acetylcholine receptor partial agonist 2‐[5‐[5‐(( S )Azetidin‐2‐ylmethoxy)‐3‐pyridinyl]‐3‐isoxazolyl]ethanol demonstrates antidepressive‐like behavior in animal models and a favorable ADME‐tox profile
47. DIFFERENCES BETWEEN TG2576- AND APP/PS1 MICE IN HIGH-THROUGHPUT BEHAVIORAL SCREENING CORRELATES WITH DIFFERENCES IN BRAIN PATHOLOGY
48. EFFECTS OF TREATMENT WITH DOXYCYCLINE ON BEHAVIOR, NEUROINFLAMMATION AND BRAIN PATHOLOGY IN THE RTG-4510 MOUSE MODEL
49. SAHA Enhances Synaptic Function and Plasticity In Vitro but Has Limited Brain Availability In Vivo and Does Not Impact Cognition
50. Chemistry, Pharmacology, and Behavioral Studies Identify Chiral Cyclopropanes as Selective α4β2-Nicotinic Acetylcholine Receptor Partial Agonists Exhibiting an Antidepressant Profile. Part II
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.